Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

39.70p
   
  • Change Today:
      0.20p
  • 52 Week High: 71.80
  • 52 Week Low: 34.50
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 866,514
  • Market Cap: £214.54m
  • RiskGrade: 119

Thursday broker round-up

By Caoimhe Toman

Date: Thursday 07 Jun 2018

LONDON (ShareCast) - (Sharecast News) - Alliance Pharma: Numis downgrades to add with a target price of 99p.
Inchcape: Deutsche Bank reiterates buy.

WH Smith: Deutsche Bank reiterates hold.

Keller Group: Barclays initiates at overweight with a target price of 1,400p.

Balfour Beatty: Barclays initiates at equal weight with a target price of 310p.

Kier Group: Barclays initiates with an underweight recommendation and a target price of 995p.

Whitbread: Barclays reiterates equal weight with a target price of 4,400.

Merlin: Barclays reiterates overweight with a target price of 400p.

IHG: Barclays stays at equal weight with a target price of 4,500p.

CMC Markets: Shore Capital Markets upgrades to buy.

Renewi: Kepler Cheuvreux initiates hold with a target price of 99p.

Greencore: Kepler Cheuvreux reiterates buy with a target price of 235p.

Marston's: Numis upgrades to add with a target price of 125p.

On The Beach Group: Numis upgrades to buy with a target price of 663p.

RWS Holdings: Numis upgrades to buy with a target price of 450p.

ITE Group: Canaccord reiterates hold with a target price of 154p.

Serco Group: UBS reiterates buy with a target price of 140p.

Workspace: Berenberg reiterates buy with a target price of 1,250p.

RPC: Berenberg reiterates hold with a target price of 880p.

Plus500: Berenberg reiterates buy with a target price of 1,880p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 39.70p
Change Today 0.20p
% Change 0.51 %
52 Week High 71.80
52 Week Low 34.50
Volume 866,514
Shares Issued 540.40m
Market Cap £214.54m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
79.58% above the market average79.58% above the market average79.58% above the market average79.58% above the market average79.58% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.77% below the market average67.77% below the market average67.77% below the market average67.77% below the market average67.77% below the market average
1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average
Income
8.33% below the market average8.33% below the market average8.33% below the market average8.33% below the market average8.33% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Growth
89.08% below the market average89.08% below the market average89.08% below the market average89.08% below the market average89.08% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 28-Mar-2024

Time Volume / Share Price
16:35 66,726 @ 39.70p
16:35 196 @ 39.70p
16:35 738 @ 39.70p
16:35 62 @ 39.70p
16:35 661 @ 39.70p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page